MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 25.61

Change

-0.21 (-0.81)%

Market Cap

CAD 0.12B

Volume

400.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.48 (-1.37%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.15 (-0.49%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.25 (+1.00%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.43 (-1.15%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.32 (+0.65%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.12 (+1.08%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.10 (-0.44%)

CAD 2.78B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.11% 67% D+ 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.11% 66% D+ 54% F
Trailing 12 Months  
Capital Gain 8.33% 64% D 60% D-
Dividend Return 2.05% 55% F 38% F
Total Return 10.38% 66% D+ 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.41% 52% F 47% F
Dividend Return 3.94% 50% F 41% F
Total Return 0.53% 58% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 9.50% 51% F 74% C
Risk Adjusted Return 41.49% 47% F 53% F
Market Capitalization 0.12B 66% D+ 37% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.